Global Cardiac Rhythm Management (CRM) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Cardiac Rhythm Management (CRM) Market Research Report 2024
Cardiac Rhythm Management Device is a medical device which uses electrical impulses, delivered by electrodes contracting the heart muscles, to regulate the beating of the heart.
A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
According to MRAResearch’s new survey, global Cardiac Rhythm Management (CRM) market is projected to reach US$ 15290 million in 2033, increasing from US$ 12120 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardiac Rhythm Management (CRM) market research.
North America is the largest Cardiac Rhythm Management (CRM) Devices market with about 87% market share. Europe is follower, accounting for about 11% market share.The key manufacturers are Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix etc. Top 3 companies occupied about 88% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cardiac Rhythm Management (CRM) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
LivaNova
Physio-Control
Schiller
Medtronic
Abbott
Boston Scientific
Koninklijke Philips
Zoll Medical
Biotronik
Segment by Type
Pacemaker
Defibrillator
Cardiac Resynchronization Therapy
Hospitals
Home Health Care
Ambulatory Services
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cardiac Rhythm Management (CRM) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
A cardiac rhythm management device (CRMD) refers to any permanently implanted cardiac pacemaker or any implantable cardioverter-defibrillator (ICD). The term CRMD also refers to any cardiac resynchronization device. The term CRT refers to a CRMD that provides cardiac resynchronization therapy using biventricular pacing techniques.
According to MRAResearch’s new survey, global Cardiac Rhythm Management (CRM) market is projected to reach US$ 15290 million in 2033, increasing from US$ 12120 million in 2022, with the CAGR of 3.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardiac Rhythm Management (CRM) market research.
North America is the largest Cardiac Rhythm Management (CRM) Devices market with about 87% market share. Europe is follower, accounting for about 11% market share.The key manufacturers are Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, Lepu (Qinming Medical), IMZ, Cardioelectronica, Pacetronix etc. Top 3 companies occupied about 88% market share.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cardiac Rhythm Management (CRM) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
LivaNova
Physio-Control
Schiller
Medtronic
Abbott
Boston Scientific
Koninklijke Philips
Zoll Medical
Biotronik
Segment by Type
Pacemaker
Defibrillator
Cardiac Resynchronization Therapy
Segment by Application
Hospitals
Home Health Care
Ambulatory Services
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cardiac Rhythm Management (CRM) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source